Clinical Trials Logo
  1. Home
  2. Abdominal Aortic Aneurysm
  3. NCT02485496
  4. Details
NCT02485496 Clinical Trial

E-tegra Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms

Abdominal Aortic Aneurysm Clinical Trial

— SECURE  

Official title:
SECURE - A poSt-market Registry in Patients With infrarEnal aortiC Aneurysm Undergoing endovasculaR Stenting With the New E-tegra Stent Graft System

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT02485496
Other study ID # SECURE
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date June 2015
Est. completion date December 2021

Study information
Verified date May 2022
Source JOTEC GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate clinical and technical success as well as safety and feasibility of the E-tegra Stent Graft System used in endovascular treatment of infrarenal aortic aneurysm.

Recruitment information / eligibility
Status Terminated
Enrollment 38
Est. completion date December 2021
Est. primary completion date July 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients must comply with the indications for use - Patient must have an infrarenal aortic aneurysm with diameter >5cm or an infrarenal aortic aneurysm with 4 to 5cm that has increased in size by 0.5cm in the last 6 months - Patient must be available for the appropriate follow-up times for the duration of the study - Patient has signed the informed consent before intervention Exclusion Criteria: - Patients with one of the contraindications as indicated in the instructions for use - Patients with infectious aneurysm - Patients with inflammatory aneurysm - Patients with pseudoaneurysm - Patients with ruptured or traumatic aneurysm - Patients with suprarenal, juxtarenal, or pararenal aneurysm - Patients with aortic dissection - Patients with a reversed conical neck that is defined as a >3mm distal increase over a 15mm length - Patients who have a congenital degenerative Collagen disease or connective tissue disorder - Patients with thrombocytopenia - Patients with creatinine >2.4 mg/dl immediately before the Intervention - Patients with hyperthyreosis - Patients with malignancy needing chemotherapy or Radiation - Patients who are enrolled in another clinical study - Patients with life expectancy of less than 24 months

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Endovascular abdominal repair

Locations
Country Name City State
France CHU Nantes Nantes
France CHU Pontchaillou Rennes
Germany Klinikum Chemnitz Chemnitz
Germany Universitätsklinikum Leipzig Leipzig
Poland Szpital Uniwersytecki im. dr. Antoniego Jurasza Bydgoszcz
Poland Samodzielny Publiczny Szpital Kliniczny Nr 1 Lublin
Poland Samodzielny Publiczny Centralny Szpital Kliniczny Warszawa
Spain Hospital Joan XXIII Tarragona
Spain Hospital Clinico Universitario Valladolid Valladolid
Switzerland Inselspital - Universitätsspital Bern

Sponsors (1)
Lead Sponsor Collaborator
JOTEC GmbH

Countries where clinical trial is conducted

France,  Germany,  Poland,  Spain,  Switzerland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Rate of aneurysm rupture and aneurysm related death 2 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04227054 - Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks N/A
Active, not recruiting NCT03687489 - Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System N/A
Active, not recruiting NCT03507413 - Metformin Therapy in Non-diabetic AAA Patients Phase 2/Phase 3
Not yet recruiting NCT05756283 - The PREHAAAB Trial: Multimodal Prehabilitation for Patients Awaiting Open Abdominal Aortic Aneurysm Repair N/A
Not yet recruiting NCT04089241 - Fusion of CT Angiography With 3D Contrast Ultrasound as a Method for Follow up for Endovascular Aneurysm Repair N/A
Active, not recruiting NCT02604303 - A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms
Completed NCT02224794 - LIFE Study: Least Invasive Fast-Track EVAR
Terminated NCT02469376 - Evaluation of a New Imagingtechnologie for Thrombosis Phase 1
Completed NCT02229006 - Sodium Fluoride Imaging of Abdominal Aortic Aneurysms N/A
Terminated NCT01843335 - Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair N/A
Terminated NCT01425242 - Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension N/A
Completed NCT01118520 - AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK) Phase 2
Completed NCT00746122 - Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair N/A
Completed NCT03952780 - Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
Completed NCT00583414 - Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients N/A
Recruiting NCT05864560 - Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up
Completed NCT01683084 - Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms Phase 4
Active, not recruiting NCT03180996 - Global Fenestrated Anaconda Clinical sTudy
Completed NCT02493296 - The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study
Completed NCT03320408 - Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers